Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Revive Therapeutics Announces Research Collaboration with PharmaTher for Development of Psilocybin in Cancer and Discovery of Novel Uses of Psychedelics
Thursday, November 19, 2020Revive Therapeutics Ltd a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders is pleased to announce it has entered into an exclusive research collaboration agreement with Pharm...
InMed Pharmaceuticals and BayMedica Announce Collaboration for Manufacturing and Testing of Novel Cannabinoid Therapeutics
Thursday, November 19, 2020InMed Pharmaceuticals Inc a clinicalstage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol CBN and BayMedica Inc a company specializing in the...
Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases
Wednesday, November 18, 2020Lead Pharma a clinical stage pharmaceutical company designing and developing innovative medicines for the treatment of immune mediated diseases and cancer today announced that it has entered into a collaboration and license agreement with Roche to de...
Samsung Biologics announces strategic manufacturing partnership with Lilly to accelerate delivery of COVID-19 antibody treatments
Wednesday, November 18, 2020Samsung Biologics partnership with Eli Lilly and Company is expected to greatly accelerate the global supply for Lillys COVID antibody therapies through a longterm manufacturing agreement with the ultimate goal of making antibody treatments more glob...
Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators
Tuesday, November 17, 2020Assembly Biosciences Inc and Door Pharmaceuticals LLC announced that the companies have signed an exclusive twoyear collaboration and option agreement focused on the development of a novel class of hepatitis B virus HBV core protein modulators
Aeterna Zentaris Amends License Agreement with Novo Nordisk for Commercialization and Development of Macimorelin
Tuesday, November 17, 2020Aeterna Zentaris Inc a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests announced that through a whollyowned subsdiary it has entered into an amendment the Amendment of its existing License Agreemen...
Olema Oncology Announces Clinical Trial Agreement to Evaluate OP-1250 in Combination with Palbociclib (IBRANCE®) in Advanced Metastatic Breast Cancer
Monday, November 16, 2020Olema Oncology a clinicalstage biopharmaceutical company focused on the discovery development and commercialization of targeted therapies for womens cancers announced a clinical trial agreement to evaluate OP a complete estrogen receptor ER antagonis...
Jubilant Therapeutics and OneThree Biotech Collaborate to Advance Precision Oncology
Friday, November 13, 2020Jubilant Therapeutics Inc Jubilant a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases and OneThree Biotech a company redesigning drug discovery with biologydriven artific...
Taiho and Lung Therapeutics Enter Into an Exclusive License Agreement in Japan for LTI-01, Treatment for Loculated Pleural Effusions
Friday, November 13, 2020Taiho Pharmaceutical Co Ltd and Lung Therapeutics Inc Lung Tx announced an exclusive license agreement of LTI a recombinant human singlechain urokinase plasminogen activator currently under development by Lung Tx for loculated pleural effusions for t...
Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2
Thursday, November 12, 2020Pfizer and BioNTech SE announced that they have reached an agreement with the European Commission to supply million doses of their investigational BNTb mRNAbased vaccine candidate against SARSCoV to European Union EU Member States with an option for...
